Bioreactors Market to Grow at a CAGR of 7.3% to reach US$ 5,169.01 Million from 2020 to 2027

Bioreactors Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product Class (Benchtop (UpTo15 L), Pilot Scale (15– 1000 L), Industrial Scale(>1000 L)), Material (Glass, Stainless Steel, Single-Use), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User (Research and development organizations, Biopharma Manufacturers, Contract Manufacturing Organizations (CMOs)), and Geography

Publication Month: May 2020 | Report Code: TIPHE100000880 | No. of Pages: 194 | Category: Biotechnology | Status: Published
Covid

 

The bioreactors market was valued atUS$ 2,958.50 million in 2019 and is projected to reach US$5,169.01 million by2027; it is expected to grow at a CAGR of 7.3% from 2020 to 2027.

 

A bioreactor is a device or system engineered or manufactured to supportbiologically active environment. These are vessels in which a chemical processesinvolving organisms or biochemically active substances derived from suchorganisms are carried out.The increasing adoption ofsingle-use bioreactors, and rapid growth of the pharmaceuticals andbiotechnology industries are among the prime factors driving the bioreactorsmarket. Additionally,increasing number of technology and distribution collaborations is anticipatedto drive the market growth in the coming years.However, stringent governmentregulations hamper the growth of the market. The developing healthcareinfrastructure and increasing investments by biopharmaceutical companies are projectedgenerate lucrative opportunities for the growth of the market.

 

Lucrative Regional Market for Bioreactors


Lucrative Regional Market for Bioreactors

Get more information on this report :


MarketInsights

Rapid Growth of Pharmaceuticals and Biotechnology Industries

In recent years, the pharmaceutical industry has been growing at anunprecedented pace. Big pharmaceutical companies and contract researchorganizations (CROs) are coming up with new medicines and therapy forms totreat a wide range of indications.

 

The biopharmaceuticals market is increasing. The strong demand forbiologics and biosimilars has driven the growth of the industry. Thebiopharmaceutical industry is one of the most significant contributors to theeconomy. The US is the largest market for biopharmaceuticals and leader inbiopharmaceutical R&D. As per the Pharmaceutical Research and ManufacturersAssociation (PhRMA), the US firms conduct over half the world's R&D inpharmaceuticals (US$ 75 billion) and hold the highest number of patents in newmedicines. Besides development economies, there have been rapid growthwitnesses in the research environment in emerging economies such as Brazil,China, and India. Factors such as increasing biologics approval, growingbiosimilar pipeline, and increasing investment in research activities are primefactors facilitating the growth of the industry.

 

Moreover, biopharmaceutical research activities are gaining pace inemerging economies such as Brazil, China, and India, and offering lucrativeopportunities for the growth of the market. Apart from this, increasingapprovals in gene and cell therapies are favoring the growth of the market. Theapproved gene therapies are Glybera-used to treat Lipoprotein LipaseDeficiency, and Strimvelis- treating ADA-Severe Combined Immuno Deficiency.


Cell Insights

Based on cell, the bioreactors market is segmented into mammaliancells, bacterial cells, yeast cells, and others. In 2019 mammalian cells heldthe largest share of the market. However, Yeast cells segment is estimated to registerthe highest CAGR in the market during the forecast period.

 

Bioreactors Market, by Cell– 2019 and 2027


Bioreactors Market, by Cell– 2019 and 2027

Get more information on this report :


Molecule Insights

Based on molecule, the bioreactors market is segmented into monoclonalantibodies, vaccines, recombinant proteins, stem cells, gene therapy, andothers. The monoclonal antibodies segment held the largest share of the marketin 2019.However, the stem cells segment is estimated to register the highestCAGR in the market during the forecast period.

 

Product Class

Based on product class, the bioreactors market is segmentedintobenchtop (Up To15 L), pilot scale (15 – 1000 L) and industrial scale(>1000 L). The benchtop (Up To15 L) segment held the largest share of themarket in 2019. However, pilot scale (15 – 1000 L) segment is estimated toregister the highest CAGR in the market during the forecast period.

 

Material

Based on material, the bioreactors market is segmented into glass,stainless steel and single-use. The stainless steel segment held the largestshare of the market in 2019. However, single-use segment is estimated toregister the highest CAGR in the market during the forecast period.

 

Technology Insights

Based on technology, the bioreactors market is segmented into wave-inducedmotion SUB, stirred SUB, single-use bubble column, and others. In 2019, the wave-inducedmotion SUB segment held the largest share of the market.Increasing research anddevelopment spending across the globe on drug development are projected todrive the growth of the market for this segment during the forecast period. However,the stirred SUB technology segment is likely to register the highest CAGRduring the forecast period.

 

End User Insights

Based on end user,the bioreactors market is segmented into research anddevelopment organizations, biopharma manufacturers, and contract manufacturingorganizations (CMOs). In 2019, biopharma manufacturers segment held the largestshare of the market. The segment is also expected to register the fastest CAGR duringthe forecast period, and the projected growth of the market for this segment isascribed to the increasing adoption of bioreactors in biopharmaceuticalsmanufacturing plants.

 

StrategicInsights

Growing number of drug discovery projects, coupled with increasingadoption of bioreactors for biochemical activities, are projected to drive themarket growth during the forecast period. Additionally, expanding capabilitiesof existing bioreactors on the back of the extended innovation processes arealso expected to offer lucrative opportunitiesto the market players. The companiesoperating in the bioreactorsmarketadopt the strategy ofcollaborations toenlarge customer base around the world, which also enables them to maintaintheir brand name globally.

 

BioreactorsMarket– By Product Class

  • Benchtop (UpTo15 L)
  • Pilot Scale (15– 1000 L)
  • IndustrialScale (>1000 L)

 

BioreactorsMarket– By Material

  • Glass
  • Stainless Steel
  • Single-Use

 

Bioreactors Market– By Cell

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Others


Bioreactors Market– By Molecule

  • MonoclonalAntibodies
  • Vaccines
  • RecombinantProteins
  • Stem Cells
  • Gene Therapy
  • Others


Bioreactors Market– By Technology

  • Induced MotionSUB
  • Stirred SUB
  • Single-UseBubble Column
  • Others


Bioreactors Market – By End User

  • Research anddevelopment organizations
  • BiopharmaManufacturers
  • ContractManufacturing Organizations (CMOs)


Bioreactors Market–By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America and Central America
    • Brazil
    • Argentina
    • Rest of South America

 

CompanyProfiles

  • Thermo Fisher Scientific Inc.
  • Pall Corporation (Danaher)
  • Sartorius AG
  • PBS Biotech, Inc.
  • GEA Group
  • Applikon Biotechnology BV
  • Merck KGaA
  • General Electric Company
  • Cellexus
  • bbi-biotech GmbH
  • Solaris Biotechnology SRL
  • Infors AG
  • Eppendorf AG


1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        GlobalBioreactors Market– By Product Class

1.3.2        GlobalBioreactors Market– By Material

1.3.3        GlobalBioreactors Market– By Cell

1.3.4        GlobalBioreactors Market– By Molecule

1.3.5        Global BioreactorsMarket– By Technology

1.3.6        GlobalBioreactors Market– By End User

1.3.7        GlobalBioreactors Market– By Geography

2.             Bioreactors Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Bioreactors Market– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America –PEST Analysis

4.2.2        Europe– PESTAnalysis

4.2.3        Asia Pacific–PEST Analysis

4.2.4        Middle East& South Africa– PEST Analysis

4.2.5        South andCentral America – PEST Analysis

4.3       Expert Opinion

5.             Global Bioreactors Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        IncreasingAdoption of Single-Use Bioreactors

5.1.2        Rapid Growth ofPharmaceutical and Biotechnology Industry

5.2       Market Restraints

5.2.1        StringentRegulatory Framework

5.3       Market Opportunities

5.3.1        Rising Demand ofPersonalized Medicine

5.4       Future Trends

5.4.1        TechnologicalAdvancements in Bioreactors

5.5       Impact analysis

6.             Bioreactors Market– Global Analysis

6.1       Global Bioreactors Market Revenue Forecast And Analysis

6.2       Global Bioreactors Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Global Bioreactors Market Analysis – By Product Class

7.1       Overview

7.2       Bioreactors Market Share, by Product Class, 2019 and 2027 (%)

7.3       Benchtop (Up To15 L)

7.3.1        Overview

7.3.2        Benchtop (UpTo15 L): Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

7.4       Pilot Scale (15 – 1000 L)

7.4.1        Overview

7.4.2        Pilot Scale (15– 1000 L): Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

7.5       Industrial Scale (>1000 L))

7.5.1        Overview

7.5.2        Industrial Scale(>1000 L)): Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

8.             Global Bioreactors Market Analysis – By Material

8.1       Overview

8.2       Bioreactors Market Share, by Material, 2019 and 2027 (%)

8.3       Glass

8.3.1        Overview

8.3.2        Glass:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

8.4       Stainless Steel

8.4.1        Overview

8.4.2        Stainless Steel:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

8.5       Single-Use

8.5.1        Overview

8.5.2        Single-Use:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

9.             Global Bioreactors Market Analysis – By Cell

9.1       Overview

9.2       Bioreactors Market Share, by Cell, 2019 and 2027 (%)

9.3       Mammalian Cells

9.3.1        Overview

9.3.2        Mammalian Cells:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

9.4       Bacterial Cells

9.4.1        Overview

9.4.2        Bacterial cellsManufacturing: Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

9.5       Yeast Cells

9.5.1        Overview

9.5.2        Yeast cells:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

9.6       Others

9.6.1        Overview

9.6.2        Others:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

10.          Global Bioreactors Market Analysis – By Molecule

10.1    Overview

10.2    Bioreactors Market Share, by Molecule, 2019 and 2027 (%)

10.3    Monoclonal Antibodies

10.3.1     Overview

10.3.2     MonoclonalAntibodies: Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

10.4    Vaccines

10.4.1     Overview

10.4.2     Vaccines:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

10.5    Recombinant Proteins

10.5.1     Overview

10.5.2     RecombinantProteins: Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

10.6    Stem Cells

10.6.1     Overview

10.6.2     Stem Cells:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

10.7    Gene Therapy

10.7.1     Overview

10.7.2     Gene Therapy:Bioreactors Market– Revenue and Forecast to 2027 (US$ million)

10.8    Others

10.8.1     Overview

10.8.2     Others: BioreactorsMarket– Revenue and Forecast to 2027 (US$ million)

11.          Global Bioreactors Market Analysis– By Technology

11.1    overview

11.2    Global Bioreactors Market, By Technology 2019 & 2027 (%)

11.3    Wave-Induced Motion SUB

11.3.1     Overview

11.3.2     Wave-Induced MotionSUB Market Revenue and Forecast to 2027 (US$ Mn)

11.4    Stirred SUB

11.4.1     Overview

11.4.2     Stirred SUB:Bioreactors Market- Revenue and Forecast to 2027 (USD Million)

11.5    Single-Use Bubble Column

11.5.1     Overview

11.5.2     Single -Use BubbleColumn: Bioreactors Market- Revenue and Forecast to 2027 (USD Million)

11.6    Other Technologies

11.6.1     Overview

11.6.2     Others: BioreactorsMarket- Revenue and Forecast to 2027 (USD Million)

12.          Global Bioreactors Market Analysis – By End User

12.1    overview

12.2    Global Bioreactors Market, By End User 2019 & 2027 (%)

12.3    Research And Development Organizations

12.3.1     Overview

12.3.2     Research AndDevelopment Organizations: Bioreactors Market- Revenue and Forecast to2027  (USD Million)

12.4    Biopharma Manufacturers

12.4.1     Overview

12.4.2     BiopharmaManufacturers: Bioreactors Market- Revenue and Forecast to 2027 (USD Million)

12.5    Contract Manufacturing Organisations (CMOs)

12.5.1     Overview

12.5.2     ContractManufacturing Organisations (CMOs): Bioreactors Market- Revenue and Forecast to2027  (USD Million)

13.          Global Bioreactors Market– Geographical Analysis

13.1    North America: Bioreactors Market

13.1.1     Overview

13.1.2     North AmericaBioreactors Market Revenue And Forecasts to 2027 (US$ Mn)

13.1.3     North AmericaBioreactors Market, by Product Class – Revenue and Forecast to 2027 (USDMillion)

13.1.4     North AmericaBioreactors Market, by Material – Revenue and Forecast to 2027 (USD Million)

13.1.5     North AmericaBioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

13.1.6     North AmericaBioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.1.7     North AmericaBioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

13.1.8     North AmericaBioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

13.1.9     North America:Bioreactors Market, by Country, 2019 & 2027 (%)

13.1.9.1    US: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.1.9.1.1    US: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.1.10   US BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.1.11   US BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.1 US Bioreactors Market,by Cell – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.2 US Bioreactors Market,by Molecule – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.3 US Bioreactors Market,by Technology – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.4 US Bioreactors Market,by End User – Revenue and Forecast to 2027 (USD Million)

13.1.11.2 Canada: BioreactorsMarket – Revenue and Forecast to 2027 (USD Million)

13.1.11.2.1 Canada: BioreactorsMarket – Revenue and Forecast to 2027 (USD Million)

13.1.12   Canada BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.1.13   Canada BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.1.13.1.1 Canada BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.1.13.1.2 Canada BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.1.13.1.3 Canada BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.1.13.1.4 Canada BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.1.13.2 Mexico: BioreactorsMarket – Revenue and Forecast to 2027 (USD Million)

13.1.13.2.1 Mexico BioreactorsMarket Revenue and Forecasts to 2027 (USD Million)

13.1.14   Mexico BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.1.15   Mexico BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.1.15.1.1 Mexico BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.1.15.1.2 Mexico BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.1.15.1.3 Mexico BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.1.15.1.4 Mexico BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.2    Europe: Bioreactors Market

13.2.1     Overview

13.2.2     Europe BioreactorsMarket Revenue and Forecasts to 2027 (US$ Mn)

13.2.3     Europe BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.2.4     Europe BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.2.5     Europe BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.2.6     Europe BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.2.7     Europe BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.2.8     Europe BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.2.9     Europe: BioreactorsMarket, by Country, 2019& 2027 (%)

13.2.9.1    Germany: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.2.9.1.1    Germany: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.2.10   Germany BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.2.11   Germany BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.2.12   Germany BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.2.12.1.1 Germany BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.2.12.1.2 Germany BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.2.12.1.3 Germany BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.2.12.2 UK: Bioreactors Market– Revenue and Forecast to 2027 (USD Million)

13.2.12.2.1 UK: Bioreactors Market– Revenue and Forecast to 2027 (USD Million)

13.2.13   UK BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.2.14   UK BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.2.14.1.1 UK Bioreactors Market,by Cell – Revenue and Forecast to 2027 (USD Million)

13.2.14.1.2 UK Bioreactors Market,by Molecule – Revenue and Forecast to 2027 (USD Million)

13.2.14.1.3 UK Bioreactors Market,by Technology – Revenue and Forecast to 2027 (USD Million)

13.2.14.1.4 UK Bioreactors Market,by End User – Revenue and Forecast to 2027 (USD Million)

13.2.14.2 France: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.2.14.2.1 France: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.2.15   France BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.2.16   France BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.2.16.1.1 France BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.2.16.1.2 France BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.2.16.1.3 France BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.2.16.1.4 France BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.2.16.2 Italy BioreactorsMarket Revenue and Forecasts to 2027 (US$ Mn)

13.2.16.2.1 Italy: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.2.17   Italy BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.2.18   Italy BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.2.18.1.1 Italy BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.2.18.1.2 Italy BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.2.18.1.3 Italy BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.2.18.1.4 Italy BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.2.18.2 Spain BioreactorsMarket Revenue and Forecasts to 2027 (US$ Mn)

13.2.18.2.1 Spain: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.2.19   Spain BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.2.20   Spain BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.2.20.1.1 Spain BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.2.20.1.2 Spain BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.2.20.1.3 Spain BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.3    Asia Pacific: Bioreactors Market

13.3.1     Overview

13.3.2     Asia PacificBioreactors Market Revenue and Forecasts to 2027 (US$ Mn)

13.3.3     Asia PacificBioreactors Market, by Product Class – Revenue and Forecast to 2027 (USDMillion)

13.3.4     Asia PacificBioreactors Market, by Material – Revenue and Forecast to 2027 (USD Million)

13.3.5     Asia PacificBioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

13.3.6     Asia PacificBioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.3.7     Asia PacificBioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

13.3.8     Asia Pacific BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.3.9     Asia Pacific:Bioreactors Market, by Country, 2018 & 2027 (%)

13.3.9.1    China: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.3.9.1.1    China: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.3.10   China BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.3.11   China BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.3.12   China BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.3.12.1.1 China BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.3.12.1.2 China BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.3.12.1.3 China BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.3.12.2 Japan: BioreactorsMarket – Revenue and Forecast to 2027 (USD Million)

13.3.12.2.1 Japan: BioreactorsMarket – Revenue and Forecast to 2027 (USD Million)

13.3.13   Japan BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.3.14   Japan BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.3.15   Japan BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.3.16   Japan BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.3.17   Japan BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.3.18   Japan BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.3.18.1 India: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.3.18.1.1 India: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.3.19   India BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.3.20   India BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.3.21   India BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.3.22   India BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.3.23   India BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.3.24   India BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.3.24.1 South Korea BioreactorsMarket Revenue and Forecasts to 2027 (US$ Mn)

13.3.24.1.1 South Korea:Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

13.3.25   South KoreaBioreactors Market, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.3.26   South KoreaBioreactors Market, by Material – Revenue and Forecast to 2027 (USD Million)

13.3.26.1.1 South Korea BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.3.26.1.2 South Korea BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.3.26.1.3 South Korea BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.3.26.2 Australia BioreactorsMarket Revenue and Forecasts to 2027 (US$ Mn)

13.3.26.2.1 Australia: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.3.27   Australia BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.3.28   Australia BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.3.28.1.1 Australia BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.3.28.1.2 Australia BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.3.28.1.3 Australia BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.3.28.1.4 Australia BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.4    Middle East & Africa: Bioreactors Market

13.4.1     Middle East &Africa: Bioreactors Market - Revenue and Forecast to 2027 (USD Million)

13.4.2     Middle East &Africa Bioreactors Market, by Product Class – Revenue and Forecast to 2027 (USDMillion)

13.4.3     Middle East &Africa Bioreactors Market, by Material – Revenue and Forecast to 2027 (USDMillion)

13.4.4     Middle East andAfrica Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

13.4.5     Middle East andAfrica Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USDMillion)

13.4.6     Middle East andAfrica Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USDMillion)

13.4.7     Middle East andAfrica Bioreactors Market, by End User – Revenue and Forecast to 2027 (USDMillion)

13.4.8     Middle East &Africa: Bioreactors Market Share by Country – 2019 & 2027, (%)

13.4.8.1    UAE: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.4.8.1.1    UAE: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.4.9     UAE BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.4.10   UAE BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.4.10.1.1 UAE Bioreactors Market,by Cell – Revenue and Forecast to 2027 (USD Million)

13.4.10.1.2 UAE Bioreactors Market,by Molecule – Revenue and Forecast to 2027 (USD Million)

13.4.10.1.3 UAE Bioreactors Market,by Technology – Revenue and Forecast to 2027 (USD Million)

13.4.10.1.4 UAE Bioreactors Market,by End User – Revenue and Forecast to 2027 (USD Million)

13.4.10.2 Saudi Arabia:Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

13.4.10.2.1 Saudi Arabia:Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

13.4.11   Saudi ArabiaBioreactors Market, by Product Class – Revenue and Forecast to 2027 (USDMillion)

13.4.12   Saudi ArabiaBioreactors Market, by Material – Revenue and Forecast to 2027 (USD Million)

13.4.12.1.1 Saudi ArabiaBioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

13.4.12.1.2 Saudi ArabiaBioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.4.12.1.3 Saudi ArabiaBioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

13.4.12.1.4 Saudi ArabiaBioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

13.4.12.2 South Africa:Bioreactors Market - Revenue and Forecasts to 2027 (USD Million)

13.4.12.2.1 South Africa:Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

13.4.13   South AfricaBioreactors Market, by Product Class – Revenue and Forecast to 2027 (USDMillion)

13.4.14   South Africa BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.4.14.1.1 South AfricaBioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

13.4.14.1.2 South AfricaBioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.4.14.1.3 South AfricaBioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

13.4.14.1.4 South AfricaBioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

13.5    South and Central America: Bioreactors Market

13.5.1     South and CentralAmerica: Bioreactors Market - Revenue and Forecast to 2027 (USD Million)

13.5.2     South and CentralAmerica Bioreactors Market, by Product Class – Revenue and Forecast to2027  (USD Million)

13.5.3     South and CentralAmerica Bioreactors Market, by Material – Revenue and Forecast to 2027 (USDMillion)

13.5.4     South and CentralAmerica Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USDMillion)

13.5.5     South and CentralAmerica Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USDMillion)

13.5.6     South and CentralAmerica Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USDMillion)

13.5.7     South and CentralAmerica Bioreactors Market, by End User – Revenue and Forecast to 2027 (USDMillion)

13.5.8     South and CentralAmerica: Bioreactors Market Share by Country – 2019 & 2027, (%)

13.5.8.1    Brazil: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.5.8.1.1    Brazil: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.5.9     Brazil BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.5.10   Brazil BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.5.10.1.1 Brazil BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.5.10.1.2 Brazil BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.5.10.1.3 Brazil BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.5.10.1.4 Brazil BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

13.5.10.2 Argentina: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.5.10.2.1 Argentina: BioreactorsMarket- Revenue and Forecasts to 2027 (USD Million)

13.5.11   Argentina BioreactorsMarket, by Product Class – Revenue and Forecast to 2027 (USD Million)

13.5.12   Argentina BioreactorsMarket, by Material – Revenue and Forecast to 2027 (USD Million)

13.5.12.1.1 Argentina BioreactorsMarket, by Cell – Revenue and Forecast to 2027 (USD Million)

13.5.12.1.2 Argentina BioreactorsMarket, by Molecule – Revenue and Forecast to 2027 (USD Million)

13.5.12.1.3 Argentina BioreactorsMarket, by Technology – Revenue and Forecast to 2027 (USD Million)

13.5.12.1.4 Argentina BioreactorsMarket, by End User – Revenue and Forecast to 2027 (USD Million)

14.          Impact Of Covid-19 Pandemic On Global Bioreactors Market

14.1    North America: Impact Assessment of COVID-19 Pandemic

14.2    Europe: Impact Assessment of COVID-19 Pandemic

14.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

14.4    Rest of World: Impact Assessment of COVID-19 Pandemic

15.          Bioreactors Market – Industry Landscape

15.1    Overview

15.2    Growth Strategies Done by the Companies in the Market, (%)

15.3    Organic Developments

15.3.1     Overview

15.4    Inorganic Developments

15.4.1     Overview

16.          Company Profiles

16.1    Thermo Fisher Scientific Inc.

16.1.1     Key Facts

16.1.2     BusinessDescription

16.1.3     Products andServices

16.1.4     Financial Overview

16.1.5     SWOT Analysis

16.1.6     Key Developments

16.2    Sartorius AG

16.2.1     Key Facts

16.2.2     BusinessDescription

16.2.3     Products andServices

16.2.4     Financial Overview

16.2.5     SWOT Analysis

16.2.6     Key Developments

16.3    Pall Corporation

16.3.1     Key Facts

16.3.2     BusinessDescription

16.3.3     Products andServices

16.3.4     Financial Overview

16.3.5     SWOT Analysis

16.3.6     Key Developments

16.4    PBS Biotech, Inc.

16.4.1     Key Facts

16.4.2     BusinessDescription

16.4.3     Products andServices

16.4.4     Financial Overview

16.4.5     SWOT Analysis

16.4.6     Key Developments

16.5    General Electric Company

16.5.1     Key Facts

16.5.2     BusinessDescription

16.5.3     Products andServices

16.5.4     Financial Overview

16.5.5     SWOT Analysis

16.5.6     Key Developments

16.6    MERCK KGaA

16.6.1     Key Facts

16.6.2     BusinessDescription

16.6.3     Products andServices

16.6.4     Financial Overview

16.6.5     SWOT Analysis

16.6.6     Key Developments

16.7    Cellexus

16.7.1     Key Facts

16.7.2     BusinessDescription

16.7.3     Products andServices

16.7.4     Financial Overview

16.7.5     SWOT Analysis

16.7.6     Key Developments

16.8    bbi-biotech GmbH

16.8.1     Key Facts

16.8.2     BusinessDescription

16.8.3     Products andServices

16.8.4     Financial Overview

16.8.5     SWOT Analysis

16.8.6     Key Developments

16.9    GEA Group

16.9.1     Key Facts

16.9.2     BusinessDescription

16.9.3     Products andServices

16.9.4     Financial Overview

16.9.5     SWOT Analysis

16.9.6     Key Developments

16.10 Applikon Biotechnology BV

16.10.1   Key Facts

16.10.2   Business Description

16.10.3   Products and Services

16.10.4   Financial Overview

16.10.5   SWOT Analysis

16.10.6   Key Developments

16.11 Eppendorf AG

16.11.1   Key Facts

16.11.2   Business Description

16.11.3   Products

16.11.4   Financial Overview

16.11.5   SWOT Analysis

16.11.6   Key Developments

16.12 Infors AG

16.12.1   Key Facts

16.12.2   Business Description

16.12.3   Products and Services

16.12.4   Financial Overview

16.12.5   SWOT Analysis

16.12.6   Key Developments

16.13 Solaris Biotechnology SRL

16.13.1   Key Facts

16.13.2   Business Description

16.13.3   Products and Services

16.13.4   Financial Overview

16.13.5   SWOT Analysis

16.13.6   Key Developments

17.          Appendix

17.1    About The Insight Partners

17.2    Glossary of Terms


LIST OF TABLES

Table 1.             North America Bioreactors Market, By Product Class – Revenue AndForecast To 2027

Table 2.             North America Bioreactors Market, By Material - Revenue And ForecastTo 2027

Table 3.             North America Bioreactors Market, By Cell– Revenue And Forecast To2027

Table 4.             North America Bioreactors Market Revenue And Forecasts To 2027, ByMolecule (Us$ Million)

Table 5.             North America Bioreactor Market Revenue And Forecasts To 2027, ByTechnology (US$ Million)

Table 6.             North America Bioreactors Market Revenue And Forecasts To 2027, ByEnd User (US$ Million)

Table 7.             US Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 8.             US Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 9.             US Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USDMillion)

Table 10.          US Bioreactors Market, By Molecule – Revenue And Forecast To 2027(USD Million)

Table 11.          US Bioreactors Market, By Technology – Revenue And Forecast To 2027(USD Million)

Table 12.          US Bioreactors Market, By End User – Revenue And Forecast To 2027(USD Million)

Table 13.          Canada Bioreactors Market, By Product Class – Revenue And ForecastTo 2027

Table 14.          Canada Bioreactors Market, By Material - Revenue And Forecast To2027

Table 15.          Canada Bioreactors Market, By Cell – Revenue And Forecast To 2027(USD Million)

Table 16.          Canada Bioreactors Market, By Molecule – Revenue And Forecast To2027 (USD Million)

Table 17.          Canada Bioreactors Market, By Technology – Revenue And Forecast To2027 (USD Million)

Table 18.          Canada Bioreactors Market, By End User – Revenue And Forecast To2027 (USD Million)

Table 19.          Mexico Bioreactors Market, By Product Class – Revenue And ForecastTo 2027

Table 20.          Mexico Bioreactors Market, By Material - Revenue And Forecast To2027

Table 21.          Mexico Bioreactors Market, By Cell – Revenue And Forecast To 2027(USD Million)

Table 22.          Mexico Bioreactors Market, By Molecule – Revenue And Forecast To2027 (USD Million)

Table 23.          Mexico Bioreactors Market, By Technology – Revenue And Forecast To2027 (USD Million)

Table 24.          Mexico Bioreactors Market, By End User – Revenue And Forecast To2027 (USD Million)

Table 25.          Europe Bioreactors Market, By Product Class – Revenue And ForecastTo 2027

Table 26.          Europe Bioreactors Market, By Material - Revenue And Forecast To2027

Table 27.          Europe Bioreactors Market, By Cell– Revenue And Forecast To 2027(USD Million)

Table 28.          Europe Bioreactors Market, By Molecule– Revenue And Forecast To 2027(USD Million)

Table 29.          Europe Bioreactors Market, By Technology– Revenue And Forecast To2027 (USD Million)

Table 30.          Europe Bioreactors Market, By End User – Revenue And Forecast To2027 (USD Million)

Table 31.          Germany Bioreactors Market, By Product Class – Revenue And ForecastTo 2027

Table 32.          Germany Bioreactors Market, By Material - Revenue And Forecast To2027

Table 33.          Germany Bioreactors Market, By Cell – Revenue And Forecast To 2027(USD Million)

Table 34.          Germany Bioreactors Market, By Molecule – Revenue And Forecast To2027 (USD Million)

Table 35.          Germany Bioreactors Market, By Technology– Revenue And Forecast To2027 (USD Million)

Table 36.          Germany Bioreactors Market, By End User – Revenue And Forecast To2027 (USD Million)

Table 37.          UK Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 38.          UK Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 39.          UK Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USDMillion)

Table 40.          UK Bioreactors Market, By Molecule– Revenue And Forecast To 2027(USD Million)

Table 41.          UK Bioreactors Market, By Technology– Revenue And Forecast To 2027(USD Million)

Table 42.          UK Bioreactors Market, By End User – Revenue And Forecast To 2027(USD Million)

Table 43.          France Bioreactors Market, By Product Class – Revenue And ForecastTo 2027

Table 44.          France Bioreactors Market, By Material - Revenue And Forecast To2027

Table 45.          France Bioreactors Market, By Cell– Revenue And Forecast To 2027(USD Million)

Table 46.          France Bioreactors Market, By Molecule– Revenue And Forecast To 2027(USD Million)

Table 47.          France Bioreactors Market, By Technology – Revenue And Forecast To2027 (USD Million)

Table 48.          France Bioreactors Market, By End User – Revenue And Forecast To2027 (USD Million)

Table 49.          Italy Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 50.          Italy Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 51.          Italy Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USDMillion)

Table 52.          Italy Bioreactors Market, By Molecule – Revenue And Forecast To 2027(USD Million)

Table 53.          Italy Bioreactors Market, By Technology– Revenue And Forecast To2027 (USD Million)

Table 54.          Italy Bioreactors Market, By End User – Revenue And Forecast To 2027(USD Million)

Table 55.          Spain Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 56.          Spain Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 57.          Spain Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USDMillion)

Table 58.          Spain Bioreactors Market, By Molecule– Revenue And Forecast To 2027(USD Million)

Table 59.          Spain Bioreactors Market, By Technology– Revenue And Forecast To2027 (USD Million)

Table 60.          Spain Bioreactors Market, By End User – Revenue And Forecast To 2027(USD Million)

Table 61.          Asia Pacific Bioreactors Market, By Product Class – Revenue AndForecast To 2027

Table 62.          Asia Pacific Bioreactors Market, By Material - Revenue And ForecastTo 2027

Table 63.          Asia Pacific Bioreactors Market, By Cell– Revenue And Forecast To2027 (USD Million)

Table 64.          Asia Pacific Bioreactors Market, By Molecule– Revenue And ForecastTo 2027 (USD Million)

Table 65.          Asia Pacific Bioreactors Market, By Technology– Revenue And ForecastTo 2027 (USD Million)

Table 66.          Asia Pacific Bioreactors Market, By End User – Revenue And ForecastTo 2027 (USD Million)

Table 67.          China Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 68.          China Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 69.          China Bioreactors Market, By Cell – Revenue And Forecast To 2027(USD Million)

Table 70.          China Bioreactors Market, By Molecule – Revenue And Forecast To 2027(USD Million)

Table 71.          China Bioreactors Market, By Technology– Revenue And Forecast To2027 (USD Million)

Table 72.          China Bioreactors Market, By End User – Revenue And Forecast To 2027(USD Million)

Table 73.          Japan Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 74.          Japan Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 75.          Japan Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USDMillion)

Table 76.          Japan Bioreactors Market, By Molecule– Revenue And Forecast To 2027(USD Million)

Table 77.          Japan Bioreactors Market, By Technology– Revenue And Forecast To2027 (USD Million)

Table 78.          Japan Bioreactors Market, By End User – Revenue And Forecast To 2027(USD Million)

Table 79.          India Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 80.          India Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 81.          India Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USDMillion)

Table 82.          India Bioreactors Market, By Molecule– Revenue And Forecast To 2027(USD Million)

Table 83.          India Bioreactors Market, By Technology – Revenue And Forecast To2027 (USD Million)

Table 84.          India Bioreactors Market, By End User – Revenue And Forecast To 2027(USD Million)

Table 85.          South Korea Bioreactors Market, By Product Class – Revenue And ForecastTo 2027

Table 86.          South Korea Bioreactors Market, By Material - Revenue And ForecastTo 2027

Table 87.          South Korea Bioreactors Market, By Cell – Revenue And Forecast To2027 (USD Million)

Table 88.          South Korea Bioreactors Market, By Molecule – Revenue And ForecastTo 2027 (USD Million)

Table 89.          South Korea Bioreactors Market, By Technology– Revenue And ForecastTo 2027 (USD Million)

Table 90.          South Korea Bioreactors Market, By End User – Revenue And ForecastTo 2027 (USD Million)

Table 91.          Australia Bioreactors Market, By Product Class – Revenue AndForecast To 2027

Table 92.          Australia Bioreactors Market, By Material - Revenue And Forecast To2027

Table 93.          Australia Bioreactors Market, By Cell– Revenue And Forecast To 2027(USD Million)

Table 94.          Australia Bioreactors Market, By Molecule– Revenue And Forecast To2027 (USD Million)

Table 95.          Australia Bioreactors Market, By Technology– Revenue And Forecast To2027 (USD Million)

Table 96.          Australia Bioreactors Market, By End User – Revenue And Forecast To2027 (USD Million)

Table 97.          Middle East & Africa Bioreactors Market, By Product Class –Revenue And Forecast To 2027

Table 98.          Middle East & Africa Bioreactors Market, By Material - RevenueAnd Forecast To 2027

Table 99.          Middle East & Africa Bioreactors Market, By Cell– Revenue AndForecast To 2027

Table 100.       Middle East & Africa Bioreactors Market, By Molecule– RevenueAnd Forecast To 2027

Table 101.       Middle East & Africa Bioreactors Market, By Technology– RevenueAnd Forecast To 2027

Table 102.       Middle East & Africa Bioreactors Market, By End User– RevenueAnd Forecast To 2027

Table 103.       UAE Bioreactors Market, By Product Class – Revenue And Forecast To2027

Table 104.       UAE Bioreactors Market, By Material - Revenue And Forecast To 2027

Table 105.       UAE Bioreactors Market, By Cell– Revenue And Forecast To 2027

Table 106.       UAE Bioreactors Market, By Molecule– Revenue And Forecast To 2027

Table 107.       UAE Bioreactors Market, By Technology– Revenue And Forecast To 2027

Table 108.       UAE Bioreactors Market, By End User– Revenue And Forecast To 2027

Table 109.       Saudi Arabia Bioreactors Market, By Product Class – Revenue AndForecast To 2027

Table 110.       Saudi Arabia Bioreactors Market, By Material - Revenue And ForecastTo 2027

Table 111.       Saudi Arabia Bioreactors Market, By Cell– Revenue And Forecast To2027

Table 112.       Saudi Arabia Bioreactors Market, By Molecule– Revenue And ForecastTo 2027

Table 113.       Saudi Arabia Bioreactors Market, By Technology– Revenue And ForecastTo 2027

Table 114.       Saudi Arabia Bioreactors Market, By End User– Revenue And ForecastTo 2027

Table 115.       South Africa Bioreactors Market, By Product Class – Revenue AndForecast To 2027

Table 116.       South Africa Bioreactors Market, By Material - Revenue And ForecastTo 2027

Table 117.       South Africa Bioreactors Market, By Cell– Revenue And Forecast To2027

Table 118.       South Africa Bioreactors Market, By Molecule– Revenue And ForecastTo 2027

Table 119.       South Africa Bioreactors Market, By Technology– Revenue And ForecastTo 2027

Table 120.       South Africa Bioreactors Market, By End User– Revenue And ForecastTo 2027

Table 121.       South and Central America Bioreactors Market, By Product Class –Revenue And Forecast To 2027

Table 122.       South and Central America Bioreactors Market, By Material - RevenueAnd Forecast To 2027

Table 123.       South and Central America Bioreactors Market, By Cell– Revenue AndForecast To 2027

Table 124.       South and Central America Bioreactors Market, By Molecule– RevenueAnd Forecast To 2027

Table 125.       South and Central America Bioreactors Market, By Technology– RevenueAnd Forecast To 2027

Table 126.       South and Central America Bioreactors Market, By End User– RevenueAnd Forecast To 2027

Table 127.       Brazil Bioreactors Market, By Product Class – Revenue And ForecastTo 2027

Table 128.       Brazil Bioreactors Market, By Material - Revenue And Forecast To2027

Table 129.       Brazil Bioreactors Market, By Cell– Revenue And Forecast To 2027

Table 130.       Brazil Bioreactors Market, By Molecule– Revenue And Forecast To 2027

Table 131.       Brazil Bioreactors Market, By Technology– Revenue And Forecast To2027

Table 132.       Brazil Bioreactors Market, By End User– Revenue And Forecast To 2027

Table 133.       Argentina Bioreactors Market, By Product Class – Revenue AndForecast To 2027

Table 134.       Argentina Bioreactors Market, By Material - Revenue And Forecast To2027

Table 135.       Argentina Bioreactors Market, By Cell– Revenue And Forecast To 2027

Table 136.       Argentina Bioreactors Market, By Molecule– Revenue And Forecast To2027

Table 137.       Argentina Bioreactors Market, By Technology– Revenue And Forecast To2027

Table 138.       Argentina Bioreactors Market, By End User– Revenue And Forecast To2027

Table 139.       Organic Developments Done By Companies

Table 140.       Inorganic Developments Done By Companies

Table 141.       Glossary of Terms, Bioreactors Market

 

LIST OF FIGURES

Figure 1.           Bioreactors Market Segmentation

Figure 2.           Bioreactors Market, By Region

Figure 3.           Global Bioreactors Market Overview

Figure 4.           Mammalian Cells Segment Held Largest Share Of Cell In BioreactorsMarket

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During theForecast Period

Figure 6.           Global Bioreactors Market, By Geography (US$ Million)

Figure 7.           Global Bioreactors Market- Leading Country Markets (US$ Million)

Figure 8.           Global Bioreactors Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia pacific PEST Analysis

Figure 12.        Middle East & South Africa PEST Analysis

Figure 13.        South and Central America PEST Analysis

Figure 14.        Expert Opinion

Figure 15.        Bioreactors Market Impact Analysis of Driver and Restraints

Figure 16.        Global Bioreactors Market– Revenue Forecast And Analysis – 2019-2027

Figure 17.        Global Bioreactors Market– By Geography Forecast And Analysis –2019- 2027

Figure 18.        Market Positioning of Key Players in Global Bioreactors Market

Figure 19.        Bioreactors Market Share, by Product Class, 2019 and 2027 (%)

Figure 20.        Benchtop (Up To15 L): Bioreactors Market– Revenue and Forecast to2027 (US$ million)

Figure 21.        Pilot Scale (15 – 1000 L): Bioreactors Market– Revenue and Forecastto 2027 (US$ million)

Figure 22.        Industrial Scale (>1000 L)): Bioreactors Market– Revenue andForecast to 2027 (US$ million)

Figure 23.        Bioreactors Market Share, by Material, 2019 and 2027 (%)

Figure 24.        Glass: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 25.        Stainless Steel: Bioreactors Market– Revenue and Forecast to 2027(US$ million)

Figure 26.        Single-Use: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 27.        Bioreactors Market Share, by Cell, 2019 and 2027 (%)

Figure 28.        Mammalian Cells: Bioreactors Market– Revenue and Forecast to 2027(US$ million)

Figure 29.        Bacterial cells Manufacturing: Bioreactors Market– Revenue andForecast to 2027 (US$ million)

Figure 30.        Yeast cells: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 31.        Others: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 32.        Bioreactors Market Share, by Molecule, 2019 and 2027 (%)

Figure 33.        Monoclonal Antibodies: Bioreactors Market– Revenue and Forecast to2027 (US$ million)

Figure 34.        Vaccines: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 35.        Recombinant Proteins: Bioreactors Market– Revenue and Forecast to2027 (US$ million)

Figure 36.        Stem Cells: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 37.        Gene Therapy: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 38.        Others: Bioreactors Market– Revenue and Forecast to 2027 (US$million)

Figure 39.        Global Bioreactors Market, By Process 2019 & 2027 (%)

Figure 40.        Wave-Induced Motion SUB: Bioreactors Market – Revenue and Forecastto 2027 (US$ million)

Figure 41.        Stirred SUB: Bioreactors Market – Revenue And Forecast To 2027 (USDMillion)

Figure 42.        Single Use- Bubble Column: Bioreactors Market – Revenue And ForecastTo 2027 (USD Million)

Figure 43.        Others: Bioreactors Market – Revenue And Forecast To 2027 (USDMillion)

Figure 44.        Global Bioreactors Market, By Process 2019 & 2027 (%)

Figure 45.        Research And Development Organizations: Bioreactors Market – RevenueAnd Forecast To 2027 (USD Million)

Figure 46.        Biopharma Manufacturers: Bioreactors Market – Revenue And ForecastTo 2027 (USD Million)

Figure 47.        Contract Manufacturing Organizations (CMOs): Bioreactors Market –Revenue And Forecast To 2027  (USDMillion)

Figure 48.        North America: Bioreactors Market, by Key Country - Revenue (2019)(USD Million)

Figure 49.        North America Bioreactors Market Revenue And Forecasts to 2027 (US$Million)

Figure 50.        North America: Bioreactors Market, By Country, 2019 & 2027 (%)

Figure 51.        US: Bioreactors Market- Revenue And Forecasts to 2027 (USD Million)

Figure 52.        Canada Bioreactors Market Revenue And Forecasts To 2027 (USDMillion)

Figure 53.        Mexico: Bioreactors Market – Revenue And Forecast To 2027 (USDMillion)

Figure 54.        Europe: Bioreactors Market, By Key Country – Revenue (2019) (USDMillion)

Figure 55.        Europe Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 56.        Europe: Bioreactors Market, By Country, 2019& 2027 (%)

Figure 57.        Germany Bioreactors Market Revenue and Forecasts To 2027 (USDMillion)

Figure 58.        UK: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)

Figure 59.        France: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)

Figure 60.        Italy: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 61.        Spain: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 62.        Asia Pacific: Bioreactors Market, By Key Country – Revenue (2019)(USD Million)

Figure 63.        Asia Pacific Bioreactors Market Revenue and Forecasts to 2027 (US$Mn)

Figure 64.        Asia Pacific: Bioreactors Market, By Country, 2018 & 2027 (%)

Figure 65.        China Bioreactors Market Revenue and Forecasts To 2027 (USD Million)

Figure 66.        Japan: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 67.        India: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 68.        South Korea: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 69.        Australia: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 70.        Middle East & Africa: Bioreactors Market, By Key Country –Revenue (2019) (USD Million)

Figure 71.        Middle East & Africa: Bioreactors Market- Revenue And ForecastsTo 2027 (USD Million)

Figure 72.        Middle East & Africa: Bioreactors Market Share by Country – 2019& 2027, (%)

Figure 73.        UAE: Bioreactors Market- Revenue and Forecasts To 2027 (USD Million)

Figure 74.        Saudi Arabia: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 75.        South Africa: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 76.        South and Central America: Bioreactors Market, By Key Country –Revenue (2019) (USD Million)

Figure 77.        South and Central America: Bioreactors Market- Revenue And ForecastsTo 2027 (USD Million)

Figure 78.        South and Central America: Bioreactors Market Share by Country –2019 & 2027, (%)

Figure 79.        Brazil: Bioreactors Market- Revenue and Forecasts To 2027 (USDMillion)

Figure 80.        Argentina: Bioreactors Market- Revenue And Forecasts To 2027 (USDMillion)

Figure 81.        Impact Of Covid-19 Pandemic In North American Country Markets

Figure 82.        Impact Of Covid-19 Pandemic In Europe Country Markets

Figure 83.        Impact Of Covid-19 Pandemic In Asia-Pacific Country Markets

Figure 84.        Impact Of Covid-19 Pandemic In Rest Of World Country Markets

Figure 85.        Growth Strategies Done by the Companies in the Market, (%)





The List of Companies - Bioreactors Market


  1. Thermo Fisher ScientificInc.
  2. Pall Corporation (Danaher)
  3. Sartorius AG
  4. PBS Biotech, Inc.
  5. GEA Group
  6. Applikon Biotechnology BV
  7. Merck KGaA
  8. General Electric Company
  9. Cellexus
  10. bbi-biotech GmbH
  11. Solaris Biotechnology SRL
  12. Infors AG
  13. Eppendorf AG


  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the bioreactors market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global bioreactors market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPHE100000880
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

A bioreactor is a manufactured or engineered device or system which is for the supports a biologically active environment. The bioreactor is a vessel in which a chemical process is carried out which involves organisms or biochemically active substances derived from such organisms. This process can either be aerobic or anaerobic. These bioreactors are commonly cylindrical, ranging in size from liters to cubic meters, and are generally made of stainless steel. Bioreactors provides a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells. These are utilized in a variety of applications such as production of biopharmaceuticals, tissue engineering, and others.

Increasing adoption of single-use bioreactors for biochemical processes across the globe are driving the global bioreactors market.

Merck KGaA and Thermo Fisher Scientific Inc. are the major players in the market.

Pricing